Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa • Positive opinion paves way for first new treatment option in hidradenitis suppurativa (HS) in nearly a decade • Committee for Medicinal Products for Human Use (CHMP) opinion based.
Positive opinion paves way for first new treatment option in hidradenitis suppurativa (HS) in nearly a decade Committee for Medicinal Products for Human Use (CHMP) opinion based on robust Phase